Boehringer Ingelheim Pharmaceuticals Uses Linux NetworX Cluster to Aid in Drug Discovery

Linux Cluster Helps Pharmaceutical Company Improve Efficiency and Save Time



Apr 02, 2002, 00:00 ET from Linux NetworX

    SALT LAKE CITY, April 2 /PRNewswire/ -- Linux NetworX announced today that
 Boehringer Ingelheim Pharmaceuticals, Inc. is advancing its human healthcare
 research and development processes with a 120-processor Linux NetworX
 Evolocity(TM) cluster supercomputer.
     The Ridgefield, Conn. laboratory of Boehringer Ingelheim Pharmaceuticals
 is using the cluster supercomputer to help predict the suitability of certain
 molecules in potential drugs.  This process is ideal for a Linux cluster
 supercomputer because the same compute process is completed for hundreds of
 thousands of molecules.  Computational chemists and biologists at Boehringer
 Ingelheim Pharmaceuticals are also using the cluster to run applications to
 find the best combinations of molecules and protein binding sites for drug
 development.
     "With a 120-processor cluster, managing every aspect of the system can be
 quite overwhelming," said Dave Craska, lead systems engineer for Boehringer
 Ingelheim Pharmaceuticals, Inc.  "The ClusterWorX software from Linux NetworX
 helps alleviate the complexities of cluster management, especially when
 upgrading and propagating new releases of software."
     Before switching to a Linux NetworX cluster, scientists at Boehringer
 Ingelheim Pharmaceuticals were running the same applications on a variety of
 systems, but results were slowed because of the limited number of available
 CPUs.  After deploying the Linux NetworX cluster, information was processed
 quickly and efficiently, saving Boehringer Ingelheim Pharmaceuticals time and
 money.
     The massive amount of data computation inherent in drug design typically
 requires the power of a supercomputer class system.  Cluster technology is a
 method of linking multiple computers, or compute nodes, together to form a
 powerful, unified system.  Linux NetworX clusters can match the performance of
 traditional supercomputers for a fraction of the cost.
     "The bioinformatics industry is experiencing an enormous demand for cost-
 effective, reliable supercomputing solutions and many pharmaceutical companies
 are turning to Linux clusters to meet that need," said Clark Roundy, vice
 president of marketing at Linux NetworX.  "Companies such as Boehringer
 Ingelheim Pharmaceuticals demand quick, accurate results and Linux NetworX
 provides the management tools to ensure our customers focus on their core
 competencies instead of system management."
     Boehringer Ingelheim Pharmaceuticals' Evolocity system includes
 120 Pentium III 866 MHz processors, 50 GB of memory, an Intel 10/100 NIC
 connection and ClusterWorX cluster management software.  To ensure optimum
 cluster operation, Boehringer Ingelheim Pharmaceuticals also signed a service
 and support contract with Linux NetworX.
 
     About Boehringer Ingelheim Pharmaceuticals
     Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is
 the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield,
 CT) and a member of the Boehringer Ingelheim group of companies.  The
 Boehringer Ingelheim group of companies, with headquarters in Ingelheim
 (Germany) is one of the 20 leading pharmaceutical firms in the world and
 reported revenues of almost US $5.8 billion in 2000.  Boehringer Ingelheim,
 which has some 140 affiliated companies worldwide, focuses on human
 pharmaceuticals and animal health.  The human pharmaceuticals business, which
 accounts for 95% of sales, is comprised of prescription medicines, consumer
 health care products and chemicals and biopharmaceuticals for industrial
 customers.  Research and development, production, and distribution facilities
 are located around the globe.  In 2000, Boehringer Ingelheim spent almost US
 $914 million on R&D, equivalent to 15.6% of net sales.
     For more information on Boehringer Ingelheim, please see the international
 Internet website www.boehringer-ingelheim.com
 
     About Linux NetworX
     Linux NetworX ( www.linuxnetworx.com ) brings its powerful and easy-to-
 manage cluster technology to those demanding high performance and high
 availability systems.  Linux NetworX provides solutions for organizations
 involved in oil and gas exploration, aeronautical and chemical modeling,
 biotechnology research, graphics rendering and visual effects, Web serving,
 ISPs, ASPs, and other technological research fields.  Through its innovative
 Evolocity hardware, ICE(TM) cluster management tools and professional service
 and support, Linux NetworX provides end-to-end clustering solutions.  To date,
 the company has built some of the largest cluster systems in the world, and
 boasts numerous Fortune 500 customers.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X63122412
 
 

SOURCE Linux NetworX
    SALT LAKE CITY, April 2 /PRNewswire/ -- Linux NetworX announced today that
 Boehringer Ingelheim Pharmaceuticals, Inc. is advancing its human healthcare
 research and development processes with a 120-processor Linux NetworX
 Evolocity(TM) cluster supercomputer.
     The Ridgefield, Conn. laboratory of Boehringer Ingelheim Pharmaceuticals
 is using the cluster supercomputer to help predict the suitability of certain
 molecules in potential drugs.  This process is ideal for a Linux cluster
 supercomputer because the same compute process is completed for hundreds of
 thousands of molecules.  Computational chemists and biologists at Boehringer
 Ingelheim Pharmaceuticals are also using the cluster to run applications to
 find the best combinations of molecules and protein binding sites for drug
 development.
     "With a 120-processor cluster, managing every aspect of the system can be
 quite overwhelming," said Dave Craska, lead systems engineer for Boehringer
 Ingelheim Pharmaceuticals, Inc.  "The ClusterWorX software from Linux NetworX
 helps alleviate the complexities of cluster management, especially when
 upgrading and propagating new releases of software."
     Before switching to a Linux NetworX cluster, scientists at Boehringer
 Ingelheim Pharmaceuticals were running the same applications on a variety of
 systems, but results were slowed because of the limited number of available
 CPUs.  After deploying the Linux NetworX cluster, information was processed
 quickly and efficiently, saving Boehringer Ingelheim Pharmaceuticals time and
 money.
     The massive amount of data computation inherent in drug design typically
 requires the power of a supercomputer class system.  Cluster technology is a
 method of linking multiple computers, or compute nodes, together to form a
 powerful, unified system.  Linux NetworX clusters can match the performance of
 traditional supercomputers for a fraction of the cost.
     "The bioinformatics industry is experiencing an enormous demand for cost-
 effective, reliable supercomputing solutions and many pharmaceutical companies
 are turning to Linux clusters to meet that need," said Clark Roundy, vice
 president of marketing at Linux NetworX.  "Companies such as Boehringer
 Ingelheim Pharmaceuticals demand quick, accurate results and Linux NetworX
 provides the management tools to ensure our customers focus on their core
 competencies instead of system management."
     Boehringer Ingelheim Pharmaceuticals' Evolocity system includes
 120 Pentium III 866 MHz processors, 50 GB of memory, an Intel 10/100 NIC
 connection and ClusterWorX cluster management software.  To ensure optimum
 cluster operation, Boehringer Ingelheim Pharmaceuticals also signed a service
 and support contract with Linux NetworX.
 
     About Boehringer Ingelheim Pharmaceuticals
     Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is
 the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield,
 CT) and a member of the Boehringer Ingelheim group of companies.  The
 Boehringer Ingelheim group of companies, with headquarters in Ingelheim
 (Germany) is one of the 20 leading pharmaceutical firms in the world and
 reported revenues of almost US $5.8 billion in 2000.  Boehringer Ingelheim,
 which has some 140 affiliated companies worldwide, focuses on human
 pharmaceuticals and animal health.  The human pharmaceuticals business, which
 accounts for 95% of sales, is comprised of prescription medicines, consumer
 health care products and chemicals and biopharmaceuticals for industrial
 customers.  Research and development, production, and distribution facilities
 are located around the globe.  In 2000, Boehringer Ingelheim spent almost US
 $914 million on R&D, equivalent to 15.6% of net sales.
     For more information on Boehringer Ingelheim, please see the international
 Internet website www.boehringer-ingelheim.com
 
     About Linux NetworX
     Linux NetworX ( www.linuxnetworx.com ) brings its powerful and easy-to-
 manage cluster technology to those demanding high performance and high
 availability systems.  Linux NetworX provides solutions for organizations
 involved in oil and gas exploration, aeronautical and chemical modeling,
 biotechnology research, graphics rendering and visual effects, Web serving,
 ISPs, ASPs, and other technological research fields.  Through its innovative
 Evolocity hardware, ICE(TM) cluster management tools and professional service
 and support, Linux NetworX provides end-to-end clustering solutions.  To date,
 the company has built some of the largest cluster systems in the world, and
 boasts numerous Fortune 500 customers.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X63122412
 
 SOURCE  Linux NetworX